Product References
Progesterone regulates the endoplasmic reticulum-associated degradation and Unfolded Protein Response axis by mimicking the androgenic stimulation in prostate cancer cells.
Molecular biology reports
Erzurumlu Y,Dogan HK,Catakli D
Wed Feb 01 00:00:00 EST 2023
RNF8 up-regulates AR/ARV7 action to contribute to advanced prostate cancer progression.
Cell death & disease
Zhou T,Wang S,Song X,Liu W,Dong F,Huo Y,Zou R,Wang C,Zhang S,Liu W,Sun G,Lin L,Zeng K,Dong X,Guo Q,Yi F,Wang Z,Li X,Jiang B,Cao L,Zhao Y
Fri Apr 15 00:00:00 EDT 2022
Quercetin in Tonglong Qibi decoction ameliorates testosterone-induced benign prostatic hyperplasia in rats by regulating Nrf2 signalling pathways and oxidative stress.
Andrologia
Fu W,Chen S,Zhang Z,Chen Y,You X,Li Q
Sat Oct 01 00:00:00 EDT 2022
Prostate cancer cell proliferation is influenced by LDL-cholesterol availability and cholesteryl ester turnover.
Cancer & metabolism
Raftopulos NL,Washaya TC,Niederprüm A,Egert A,Hakeem-Sanni MF,Varney B,Aishah A,Georgieva ML,Olsson E,Dos Santos DZ,Nassar ZD,Cochran BJ,Nagarajan SR,Kakani MS,Hastings JF,Croucher DR,Rye KA,Butler LM,Grewal T,Hoy AJ
Sat Jan 15 00:00:00 EST 2022
Expansion of mouse castration-resistant intermediate prostate stem cells in vitro.
Stem cell research & therapy
Xu Y,Mu J,Zhou Z,Leng Y,Yu Y,Song X,Liu A,Zhu H,Li J,Wang D
Fri Jul 15 00:00:00 EDT 2022
Expansion of mouse castration-resistant intermediate prostate stem cells in vitro.
Stem cell research & therapy
Xu Y,Mu J,Zhou Z,Leng Y,Yu Y,Song X,Liu A,Zhu H,Li J,Wang D
Fri Jul 15 00:00:00 EDT 2022
Correction: Expansion of mouse castration-resistant intermediate prostate stem cells in vitro.
Stem cell research & therapy
Xu Y,Mu J,Zhou Z,Leng Y,Yu Y,Song X,Liu A,Zhu H,Li J,Wang D
Fri Nov 25 00:00:00 EST 2022
Correction: Expansion of mouse castration-resistant intermediate prostate stem cells in vitro.
Stem cell research & therapy
Xu Y,Mu J,Zhou Z,Leng Y,Yu Y,Song X,Liu A,Zhu H,Li J,Wang D
Fri Nov 25 00:00:00 EST 2022
α-Terthienyl induces prostate cancer cell death through inhibiting androgen receptor expression.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Gan X,Huang H,Wen J,Liu K,Yang Y,Li X,Fang G,Liu Y,Wang X
Mon Aug 01 00:00:00 EDT 2022
NCAPD3 promotes prostate cancer progression by up-regulating EZH2 and MALAT1 through STAT3 and E2F1.
Cellular signalling
Jing Z,Liu Q,Xie W,Wei Y,Liu J,Zhang Y,Zuo W,Lu S,Zhu Q,Liu P
Fri Apr 01 00:00:00 EDT 2022
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.
Clinical and translational medicine
Zhou L,Zhang C,Yang X,Liu L,Hu J,Hou Y,Tao H,Sugimura H,Chen Z,Wang L,Chen K
Tue Jun 01 00:00:00 EDT 2021
A feedback loop between the androgen receptor and 6-phosphogluoconate dehydrogenase (6PGD) drives prostate cancer growth.
eLife
Gillis JL,Hinneh JA,Ryan NK,Irani S,Moldovan M,Quek LE,Shrestha RK,Hanson AR,Xie J,Hoy AJ,Holst J,Centenera MM,Mills IG,Lynn DJ,Selth LA,Butler LM
Thu Aug 12 00:00:00 EDT 2021
KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer.
Cell death & disease
Lu D,Song Y,Yu Y,Wang D,Liu B,Chen L,Li X,Li Y,Cheng L,Lv F,Zhang P,Xing Y
Thu Aug 12 00:00:00 EDT 2021
KAT2A-mediated AR translocation into nucleus promotes abiraterone-resistance in castration-resistant prostate cancer.
Cell death & disease
Lu D,Song Y,Yu Y,Wang D,Liu B,Chen L,Li X,Li Y,Cheng L,Lv F,Zhang P,Xing Y
Thu Aug 12 00:00:00 EDT 2021
PRPF6 promotes androgen receptor/androgen receptor-variant 7 actions in castration-resistant prostate cancer cells.
International journal of biological sciences
Liu W,Wang C,Wang S,Zeng K,Wei S,Sun N,Sun G,Wang M,Zou R,Liu W,Lin L,Song H,Jin Z,Zhao Y
Mon Jan 03 00:00:00 EST 2022
ACSS3 represses prostate cancer progression through downregulating lipid droplet-associated protein PLIN3.
Theranostics
Zhou L,Song Z,Hu J,Liu L,Hou Y,Zhang X,Yang X,Chen K
Wed Aug 04 00:00:00 EDT 2021
KLF5 Is Crucial for Androgen-AR Signaling to Transactivate Genes and Promote Cell Proliferation in Prostate Cancer Cells.
Cancers
Li J,Zhang B,Liu M,Fu X,Ci X,A J,Fu C,Dong G,Wu R,Zhang Z,Fu L,Dong JT
Sat Mar 21 00:00:00 EDT 2020
Wnt5a induces and maintains prostate cancer cells dormancy in bone.
The Journal of experimental medicine
Ren D,Dai Y,Yang Q,Zhang X,Guo W,Ye L,Huang S,Chen X,Lai Y,Du H,Lin C,Peng X,Song L
Mon Feb 04 00:00:00 EST 2019
Wnt5a induces and maintains prostate cancer cells dormancy in bone.
The Journal of experimental medicine
Ren D,Dai Y,Yang Q,Zhang X,Guo W,Ye L,Huang S,Chen X,Lai Y,Du H,Lin C,Peng X,Song L
Mon Feb 04 00:00:00 EST 2019
Identification of reciprocal microRNA-mRNA pairs associated with metastatic potential disparities in human prostate cancer cells and signaling pathway analysis.
Journal of cellular biochemistry
Ma H,Wang LY,Yang RH,Zhou Y,Zhou P,Kong L
Tue Oct 01 00:00:00 EDT 2019
The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer.
Molecular cancer therapeutics
Tran LNK,Kichenadasse G,Butler LM,Centenera MM,Morel KL,Ormsby RJ,Michael MZ,Lower KM,Sykes PJ
Fri Dec 01 00:00:00 EST 2017
The Combination of Metformin and Valproic Acid Induces Synergistic Apoptosis in the Presence of p53 and Androgen Signaling in Prostate Cancer.
Molecular cancer therapeutics
Tran LNK,Kichenadasse G,Butler LM,Centenera MM,Morel KL,Ormsby RJ,Michael MZ,Lower KM,Sykes PJ
Fri Dec 01 00:00:00 EST 2017